重组人脑利钠肽辅助治疗老年心力衰竭患者的疗效及其对心功能、炎性指标的影响
- 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
- 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
- 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。
重组人脑利钠肽辅助治疗老年心力衰竭患者的疗效及其对心功
能、炎性指标的影响
孙颖;郝艳丽;李延辉;庄媛;李悦
【期刊名称】《疑难病杂志》
【年(卷),期】2017(016)001
【摘要】目的:观察重组人脑利钠肽辅助治疗老年心力衰竭患者的临床疗效及其
对心功能、炎性指标的影响。
方法选取2015年4月—2016年4月辽宁省金秋医院心血管内科收治的心力衰竭患者82例作为研究对象,随机数字表法分为观察组41例和对照组41例,对照组给予常规抗心力衰竭治疗;观察组在对照组基础上
联用重组人脑利钠肽,初始负荷剂量(1.5~2.0)μg/kg,3 min内静脉注射,然后以0.0075μg· kg-1· min-1连续静脉泵入72 h,2组患者均连续治疗7 d;比较2组患者临床疗效;左室射血分数( LVEF )、左室收缩末期内径
( LVESD )、左室舒张末期内径(LVEDD)、每搏输出量(SV)、心脏指数(CI);血清脑钠肽(BNP)、C反应蛋白(CRP)含量、血肌酐(SCr)水平;
记录不良反应。
结果观察组总有效率为90.2%,显著高于对照组的73.2%
(χ2=3.998, P =0.046);与治疗前比较2组患者治疗后LVEF明显提高,LVESD、BNP、CRP、SCr显著降低( t =10.411、4.710、34.623、5.942、3.128,6.593、1.761、19.126、3.732、1.768, P均<0.05),而LVEDD、SV、CI无明显变化( t =1.089、0.624、1.454,1.391、0.386、0.860, P均>0.05);观察组 LVEF、LVESD、BNP、CRP、SCr 改善程度明显优于对照组( t =4.029、3.047、25.666、3.893、1.738, P均<0.05);2组患者治疗期间发生体位性低血压、腹痛、头痛、
转氨酶升高、血钾升高等不良反应发生率比较,差异均无统计学意义(χ2=1.075、0.503、0.193、0.889、0.889, P均>0.05)。
结论重组人脑利钠肽辅助治疗老年心力衰竭患者能提高临床效果,改善心功能,减轻肾功能损伤和炎性反应,安全可靠,有利于患者的康复,值得临床推广应用。
%Objective To observe the clinical efficacy and changes in heart function , BNP, SCr, CRP of elderly pa-tients with heart failure in treatment with recombinant human brain natriuretic peptide .Methods Eighty-two cases of patients with heart failure in Liaoning Jinqiu Hospital internal medicine department were selected , and they were divided into the ob-servation group (41 cases) and control group (41 cases).The patients of control group were treated with conventional thera-py.On the basis of control group , the patients of observation group were treated with recombinant human brain natriuretic pep -tide ( initial loading dose (1.5 -2.0) μg /kg, intravenously within 3min, then 0.007 5μg.kg-1 .min-1 continuous intrave-nous infusion for 72h).The patients of two groups were all treated for 7 pare the clinical efficacy, adverse events and changes of the levels of left ventricular ejection fraction (LVEF), left ventricular end systolic diameter (LVESD), left ventricular end diastolic diameter ( LVEDD ) , stroke volume ( SV ) , cardiac index ( CI ) , serum brain natriuretic peptide (BNP), C reactive protein (CRP) content, serum creatinine (SCr) of the two groups.Results After the appropriate treat-ment, the patients of the observation group got a total effective rate of 90.2%, which was significantly better than the 73.2%of the control group (χ2 =3.998, P
=0.046); In the terms of LVEF, LVESD, BNP, CRP and SCr, the patients of
two groups were all significantly improved than before ( t =10.411, t
=4.710, t =34.623, t =5.942, t =3.128, t =6.593, t =1.761, t =19.126, t
=3.732, t =1.768, all P <0.05), and the patients of the observation group got more significant improvement ( t =4.029, t =3.047, t =25.666, t =3.893, t =1.738, all P <0.05);In the terms of LVEDD, SV, CI, there were no significant changes than before in both two groups ( t =1.089, t =0.624, t =1.454, t =1.391, t =0.386, t=0.860, t =0.837, t =0.571, t =0.512, all
P >0.05);There were orthostatic hypotension, abdominal pain, headache, elevated aminotransferases , elevated serum potassium and other adverse reactions occurred in both two groups during the treat -ment, and there were no statistically significant between the two g roups (χ2 =1.075,χ2
=0.503,χ2 =0.193,χ2 =0.889,χ2 =0.889, all P >0.05).Conclusion Recombinant human brain natriuretic peptide in adjuvant therapy can improve the clinical effect of elderly patients with heart failure , improve heart function , reduce the renal injury and inflammatory reaction , safe and reliable , is conducive to the rehabilitation of patients , is worthy of clinical application .
【总页数】4页(P10-13)
【作者】孙颖;郝艳丽;李延辉;庄媛;李悦
【作者单位】110016 沈阳,辽宁省金秋医院心血管内科四病房;110016 沈阳,辽宁省金秋医院心血管内科四病房;110016 沈阳,辽宁省金秋医院心血管内科四病房;110016 沈阳,辽宁省金秋医院心血管内科四病房;110016 沈阳,辽宁省金秋医院心血管内科四病房
【正文语种】中文
【相关文献】
1.重组人脑利钠肽辅助治疗老年心力衰竭的疗效及其对心功能指标的影响 [J], 于
安石
2.冻干重组人脑利钠肽联合硝酸甘油治疗老年急性心肌梗死合并心力衰竭患者的疗效及心功能分析 [J], 肖淑华;戴永淦;游慧玲;林萍
3.重组人脑利钠肽联合托伐普坦对老年慢性心力衰竭患者心功能及cTnI、CK-MB、BNP水平的影响 [J], 王小荣;靳立娟;崔荣恩
4.重组人脑利钠肽联合托伐普坦对老年慢性心力衰竭患者心功能及c Tn I、CK-MB、BNP水平的影响 [J], 王小荣;靳立娟;崔荣恩
5.重组人脑利钠肽辅助治疗老年心力衰竭患者的疗效及对心功能、炎性指标的影响[J], 马晓龙
因版权原因,仅展示原文概要,查看原文内容请购买。